Protein binding displacement interactions and their clinical importance.

Area of Science:

• Pharmacokinetics
• Drug Interactions
• Biochemistry

Background:

• Drug-protein binding is a critical pharmacokinetic parameter influencing drug disposition and efficacy.
• While plasma binding is extensively studied, tissue binding also plays a significant role in drug behavior.
• Displacement interactions at binding sites are frequently cited as a cause of drug-drug interactions.

Purpose of the Study:

• To critically evaluate the clinical significance of drug displacement from plasma and tissue binding sites.
• To differentiate between transient effects of plasma binding displacement and potentially serious consequences of tissue binding displacement.
• To identify specific clinical scenarios where plasma binding displacement interactions are clinically relevant.

Main Methods:

• Review of existing literature on drug-protein binding and displacement interactions.
• Analysis of in vitro versus in vivo data regarding the impact of drug displacement.
• Case study analysis of specific clinical situations involving drug displacement.

Main Results:

• The clinical importance of plasma binding displacement has been overestimated, largely due to in vitro data; displaced drugs typically redistribute, causing only transient increases in free drug concentrations.
• Clinically significant drug interactions attributed to plasma binding displacement often involve other mechanisms, such as altered metabolism or elimination.
• Plasma binding displacement is clinically relevant in specific situations like rapid intravenous administration, therapeutic drug monitoring, and during blood sampling with heparin locks.
• Tissue binding displacement poses a greater risk for adverse effects, as drugs are forced from tissues back into circulation, increasing plasma levels and enhancing pharmacological effects.
• Simultaneous displacement from both plasma and tissue binding sites can lead to compounded effects, including increased free drug concentrations and potential toxicity.

Conclusions:

• Plasma protein binding displacement is generally not a major cause of clinically significant drug interactions due to compensatory drug redistribution.
• Tissue binding displacement has a greater potential to cause adverse effects and toxicity by increasing circulating free drug concentrations.
• Understanding the location of drug binding (plasma vs. tissue) is crucial for predicting the clinical consequences of displacement interactions.